Genpharmasec Limited (BOM:531592)
India flag India · Delayed Price · Currency is INR
1.080
0.00 (0.00%)
At close: Nov 17, 2026

Genpharmasec Statistics

Total Valuation

Genpharmasec has a market cap or net worth of INR 598.02 million. The enterprise value is 769.68 million.

Market Cap598.02M
Enterprise Value 769.68M

Important Dates

The next estimated earnings date is Tuesday, February 9, 2027.

Earnings Date Feb 9, 2027
Ex-Dividend Date n/a

Share Statistics

Genpharmasec has 553.72 million shares outstanding. The number of shares has increased by 94.07% in one year.

Current Share Class 553.72M
Shares Outstanding 553.72M
Shares Change (YoY) +94.07%
Shares Change (QoQ) n/a
Owned by Insiders (%) 39.76%
Owned by Institutions (%) n/a
Float 319.18M

Valuation Ratios

The trailing PE ratio is 48.26.

PE Ratio 48.26
Forward PE n/a
PS Ratio 0.26
PB Ratio 0.88
P/TBV Ratio 1.20
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 30.05
EV / Sales 0.33
EV / EBITDA 21.92
EV / EBIT 95.39
EV / FCF n/a

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.36.

Current Ratio 1.20
Quick Ratio 0.54
Debt / Equity 0.36
Debt / EBITDA 6.80
Debt / FCF n/a
Interest Coverage 0.51

Financial Efficiency

Return on equity (ROE) is 2.08% and return on invested capital (ROIC) is 0.54%.

Return on Equity (ROE) 2.08%
Return on Assets (ROA) 0.39%
Return on Invested Capital (ROIC) 0.54%
Return on Capital Employed (ROCE) 1.09%
Weighted Average Cost of Capital (WACC) 5.38%
Revenue Per Employee 177.40M
Profits Per Employee 1.97M
Employee Count13
Asset Turnover 1.78
Inventory Turnover 12.89

Taxes

In the past 12 months, Genpharmasec has paid 9.81 million in taxes.

Income Tax 9.81M
Effective Tax Rate 41.61%

Stock Price Statistics

The stock price has decreased by -31.65% in the last 52 weeks. The beta is 0.31, so Genpharmasec's price volatility has been lower than the market average.

Beta (5Y) 0.31
52-Week Price Change -31.65%
50-Day Moving Average 1.08
200-Day Moving Average 1.12
Relative Strength Index (RSI) 52.52
Average Volume (20 Days) 365,024

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Genpharmasec had revenue of INR 2.31 billion and earned 25.61 million in profits. Earnings per share was 0.02.

Revenue2.31B
Gross Profit 171.26M
Operating Income 8.07M
Pretax Income 23.58M
Net Income 25.61M
EBITDA 29.01M
EBIT 8.07M
Earnings Per Share (EPS) 0.02
Full Income Statement

Balance Sheet

The company has 54.25 million in cash and 238.67 million in debt, with a net cash position of -184.42 million or -0.33 per share.

Cash & Cash Equivalents 54.25M
Total Debt 238.67M
Net Cash -184.42M
Net Cash Per Share -0.33
Equity (Book Value) 664.84M
Book Value Per Share 0.54
Working Capital 118.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -182.01 million and capital expenditures -626,000, giving a free cash flow of -182.64 million.

Operating Cash Flow -182.01M
Capital Expenditures -626,000
Depreciation & Amortization 20.94M
Net Borrowing -53.44M
Free Cash Flow -182.64M
FCF Per Share -0.33
Full Cash Flow Statement

Margins

Gross margin is 7.43%, with operating and profit margins of 0.35% and 1.11%.

Gross Margin 7.43%
Operating Margin 0.35%
Pretax Margin 1.02%
Profit Margin 1.11%
EBITDA Margin 1.26%
EBIT Margin 0.35%
FCF Margin n/a

Dividends & Yields

Genpharmasec does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -94.07%
Shareholder Yield -94.07%
Earnings Yield 2.07%
FCF Yield -30.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on April 11, 2019. It was a forward split with a ratio of 10.

Last Split Date Apr 11, 2019
Split Type Forward
Split Ratio 10

Scores

Altman Z-Score n/a
Piotroski F-Score 5